|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 9/00 | |||
| A61K 47/34 | |||
| A61P 27/02 |
| (11) | Number of the document | 3068403 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14805768.0 |
| Date of filing the European patent application | 2014-11-14 | |
| (97) | Date of publication of the European application | 2016-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/065804 |
| Date | 2014-11-14 |
| (87) | Number | WO 2015/073895 |
| Date | 2015-05-21 |
| (30) | Number | Date | Country code |
| 201361904887 P | 2013-11-15 | US |
| (72) |
SHIAH, Jane-Guo, US
BHAGAT, Rahul, US
BLANDA, Wendy M., US
NIVAGGIOLI, Thierry, US
PENG, Lin, US
CHOU, David, US
WEBER, David A., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT |
| METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT |